Featuring Ginette Okoye, MD and Temitayo Ogunleye, MD Saturday morning began with an enlightening conversation with Dr. Ginette Okoye and Dr. Temitayo Ogunleye reviewing medical literature on skin of color. While this is improving, Dr. Okoye mentioned “ there is not a lot of great research in skin of color”. Dr. Ogunleye presented a review …
Featuring Adam Friedman, MD, FAAD Dr. Adam Friedman returned for the afternoon product theater to discuss atopic dermatitis (AD) and treatment with Dupixent. Dupixent is a treatment for moderate to severe atopic dermatitis in patients 12 years of age or older whose disease is not adequately controlled with topical prescription therapies. Dr. Friedman reports “atopic …
On day two of the 16th Annual Fall Conference, Cynthia Trickett, MPAS, PA-C, DFAAPA shared her clinical insights regarding the treatment of atopic dermatitis (AD) in her lecture on Dupixent. AD is estimated to affect 3.2% of adults in the US and around 1.6 million with moderate to severe AD remain uncontrolled despite treatment. Ms. …